FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034793318> ?p ?o ?g. }

• W2034793318 endingPage "e4918" @default.
• W2034793318 startingPage "e4918" @default.
• W2034793318 abstract "Leishmania is the etiologic agent of leishmanisais, a protozoan disease whose pathogenic events are not well understood. Current therapy is suboptimal due to toxicity of the available therapeutic agents and the emergence of drug resistance. Compounding these problems is the increase in the number of cases of Leishmania-HIV coinfection, due to the overlap between the AIDS epidemic and leishmaniasis.In the present report, we have investigated the effect of HIV aspartyl peptidase inhibitors (PIs) on the Leishmania amazonensis proliferation, ultrastructure, interaction with macrophage cells and expression of classical peptidases which are directly involved in the Leishmania pathogenesis. All the HIV PIs impaired parasite growth in a dose-dependent fashion, especially nelfinavir and lopinavir. HIV PIs treatment caused profound changes in the leishmania ultrastructure as shown by transmission electron microscopy, including cytoplasm shrinking, increase in the number of lipid inclusions and some cells presenting the nucleus closely wrapped by endoplasmic reticulum resembling an autophagic process, as well as chromatin condensation which is suggestive of apoptotic death. The hydrolysis of HIV peptidase substrate by L. amazonensis extract was inhibited by pepstatin and HIV PIs, suggesting that an aspartyl peptidase may be the intracellular target of the inhibitors. The treatment with HIV PIs of either the promastigote forms preceding the interaction with macrophage cells or the amastigote forms inside macrophages drastically reduced the association indexes. Despite all these beneficial effects, the HIV PIs induced an increase in the expression of cysteine peptidase b (cpb) and the metallopeptidase gp63, two well-known virulence factors expressed by Leishmania spp.In the face of leishmaniasis/HIV overlap, it is critical to further comprehend the sophisticated interplays among Leishmania, HIV and macrophages. In addition, there are many unresolved questions related to the management of Leishmania-HIV-coinfected patients. For instance, the efficacy of therapy aimed at controlling each pathogen in coinfected individuals remains largely undefined. The results presented herein add new in vitro insight into the wide spectrum efficacy of HIV PIs and suggest that additional studies about the synergistic effects of classical antileishmanial compounds and HIV PIs in macrophages coinfected with Leishmania and HIV-1 should be performed." @default.
• W2034793318 created "2016-06-24" @default.
• W2034793318 creator A5008267222 @default.
• W2034793318 creator A5015950676 @default.
• W2034793318 creator A5044815424 @default.
• W2034793318 creator A5056224162 @default.
• W2034793318 creator A5064467724 @default.
• W2034793318 creator A5068855331 @default.
• W2034793318 creator A5069752916 @default.
• W2034793318 creator A5071995571 @default.
• W2034793318 creator A5081994354 @default.
• W2034793318 creator A5091702477 @default.
• W2034793318 date "2009-03-26" @default.
• W2034793318 modified "2023-10-16" @default.
• W2034793318 title "HIV Aspartyl Peptidase Inhibitors Interfere with Cellular Proliferation, Ultrastructure and Macrophage Infection of Leishmania amazonensis" @default.
• W2034793318 cites W1855297813 @default.
• W2034793318 cites W1965762540 @default.
• W2034793318 cites W1970405892 @default.
• W2034793318 cites W1970503898 @default.
• W2034793318 cites W1972489358 @default.
• W2034793318 cites W1977834172 @default.
• W2034793318 cites W1980886769 @default.
• W2034793318 cites W1983545930 @default.
• W2034793318 cites W1984718352 @default.
• W2034793318 cites W1988371755 @default.
• W2034793318 cites W1990956809 @default.
• W2034793318 cites W1995028301 @default.
• W2034793318 cites W1995789505 @default.
• W2034793318 cites W2003887174 @default.
• W2034793318 cites W2008229658 @default.
• W2034793318 cites W2016040396 @default.
• W2034793318 cites W2020014357 @default.
• W2034793318 cites W2020216656 @default.
• W2034793318 cites W2022927897 @default.
• W2034793318 cites W2023261505 @default.
• W2034793318 cites W2024443399 @default.
• W2034793318 cites W2025933441 @default.
• W2034793318 cites W2027443714 @default.
• W2034793318 cites W2027953606 @default.
• W2034793318 cites W2036457196 @default.
• W2034793318 cites W2045390653 @default.
• W2034793318 cites W2048636029 @default.
• W2034793318 cites W2050893503 @default.
• W2034793318 cites W2051490501 @default.
• W2034793318 cites W2052833785 @default.
• W2034793318 cites W2056624166 @default.
• W2034793318 cites W2059190042 @default.
• W2034793318 cites W2066845465 @default.
• W2034793318 cites W2067692987 @default.
• W2034793318 cites W2072792745 @default.
• W2034793318 cites W2080950099 @default.
• W2034793318 cites W2083362942 @default.
• W2034793318 cites W2091837929 @default.
• W2034793318 cites W2112904488 @default.
• W2034793318 cites W2124286005 @default.
• W2034793318 cites W2148589496 @default.
• W2034793318 cites W2150351369 @default.
• W2034793318 cites W2150386194 @default.
• W2034793318 cites W2154324414 @default.
• W2034793318 cites W2156382913 @default.
• W2034793318 cites W2160455203 @default.
• W2034793318 cites W2160745165 @default.
• W2034793318 cites W2170303823 @default.
• W2034793318 cites W2171829787 @default.
• W2034793318 cites W3026032990 @default.
• W2034793318 doi "https://doi.org/10.1371/journal.pone.0004918" @default.
• W2034793318 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2656615" @default.
• W2034793318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19325703" @default.
• W2034793318 hasPublicationYear "2009" @default.
• W2034793318 type Work @default.
• W2034793318 sameAs 2034793318 @default.
• W2034793318 citedByCount "64" @default.
• W2034793318 countsByYear W20347933182012 @default.
• W2034793318 countsByYear W20347933182013 @default.
• W2034793318 countsByYear W20347933182014 @default.
• W2034793318 countsByYear W20347933182015 @default.
• W2034793318 countsByYear W20347933182016 @default.
• W2034793318 countsByYear W20347933182017 @default.
• W2034793318 countsByYear W20347933182018 @default.
• W2034793318 countsByYear W20347933182019 @default.
• W2034793318 countsByYear W20347933182020 @default.
• W2034793318 countsByYear W20347933182021 @default.
• W2034793318 countsByYear W20347933182022 @default.
• W2034793318 countsByYear W20347933182023 @default.
• W2034793318 crossrefType "journal-article" @default.
• W2034793318 hasAuthorship W2034793318A5008267222 @default.
• W2034793318 hasAuthorship W2034793318A5015950676 @default.
• W2034793318 hasAuthorship W2034793318A5044815424 @default.
• W2034793318 hasAuthorship W2034793318A5056224162 @default.
• W2034793318 hasAuthorship W2034793318A5064467724 @default.
• W2034793318 hasAuthorship W2034793318A5068855331 @default.
• W2034793318 hasAuthorship W2034793318A5069752916 @default.
• W2034793318 hasAuthorship W2034793318A5071995571 @default.
• W2034793318 hasAuthorship W2034793318A5081994354 @default.
• W2034793318 hasAuthorship W2034793318A5091702477 @default.
• W2034793318 hasBestOaLocation W20347933181 @default.
• W2034793318 hasConcept C136764020 @default.
• W2034793318 hasConcept C202751555 @default.

• next